Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib, Temozolomide, and Radiation in Newly Diagnosed GBM with Unmethylated MGMT
NCT02928575Phase 2Unknown
- Sponsor
- Bassam Abdulkarim
- Start
- Aug 2012
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of sunitinib in glioblastoma multiforme (GBM), sponsored by Bassam Abdulkarim. Status: unknown.
02
Drugs
sunitinib
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT02928575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02928575.